Molecular approaches to pathogenesis study of Burkholderia cenocepacia, an important cystic fibrosis opportunistic bacterium

Applied Microbiology and Biotechnology

Volumn 92, Issue 5, 2011, Pages 887-895

  Bazzini, Silvia ^a   Udine, Claudia ^a   Riccardi, Giovanna ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Burkholderia; Drug efflux transporters; Pathogenesis; RND

Indexed keywords

BURKHOLDERIA; BURKHOLDERIA CEPACIA COMPLEX; CLINICAL ISOLATES; CYSTIC FIBROSIS; DELETION MUTANTS; DRUG RESISTANCE; ECOLOGICAL NICHE; EFFLUX PUMPS; EFFLUX TRANSPORTER; GRAM-NEGATIVE BACTERIA; HOST-PATHOGEN INTERACTIONS; INTRINSIC RESISTANCE; MICROARRAY ANALYSIS; MOLECULAR APPROACH; MOLECULAR TECHNIQUES; MULTIDRUG RESISTANCE; PATHOGENESIS; RESISTANCE MECHANISMS; RESISTANCE-NODULATION-CELL DIVISIONS; RND; TRANSCRIPTOMES;

ANTIBIOTICS; BACTERIA; CELL PROLIFERATION; GENES;

DRUG INTERACTIONS;

ABC TRANSPORTER; AMINOGLYCOSIDE; ANTIPORTER; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; COMPLEMENTARY DNA; ERYTHROMYCIN; GENTAMICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MAJOR FACILITATOR TRANSPORTER; MULTIDRUG AND TOXIC EFFLUX TRANSPORTER; N ACYLHOMOSERINE LACTONE; POLYMYXIN DERIVATIVE; RESISTANCE NODULATION DIVISION TRANSPORTER; SMALL MULTIDRUG RESISTANCE TRANSPORTER; STREPTOMYCIN; TRANSCRIPTOME; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRIMETHOPRIM; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIBIOTICS; BACTERIUM; DISEASE RESISTANCE; DRUG RESISTANCE; GENOME; HOST-PATHOGEN INTERACTION; INFECTIOUS DISEASE; MOLECULAR ANALYSIS; MUTATION; PATHOGENICITY;

ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL OUTER MEMBRANE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BIOFILM; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA INFECTION; BURKHOLDERIA PSEUDOMALLEI; CYSTIC FIBROSIS; DNA MICROARRAY; DRUG TARGETING; GENE DELETION; GENE SEQUENCE; HOST PATHOGEN INTERACTION; MICROARRAY ANALYSIS; MOLECULAR BIOLOGY; MULTIDRUG RESISTANCE; NODULATION; NONHUMAN; OPERON; PATHOGENESIS; PATHOGENICITY; PHENOTYPE; PROTEOMICS; QUORUM SENSING; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS;

ANIMALS; ANTI-BACTERIAL AGENTS; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA INFECTIONS; CYSTIC FIBROSIS; DRUG RESISTANCE, BACTERIAL; GENETIC TECHNIQUES; HUMANS;

BACTERIA (MICROORGANISMS); BURKHOLDERIA; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CEPACIA COMPLEX; NEGIBACTERIA;

EID: 82355190244     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-011-3616-5     Document Type: Review

References (80)

1. H Akama M Kanemaki M Yoshimura T Tsukihara T Kashiwagi H Yoneyama S Narita A Nakagawa T Nakae 2004 Crystal structure of the drug discharge outer membrane protein, OprM, of Pseudomonas aeruginosa: dual modes of membrane anchoring and occluded cavity end J Biol Chem 279 52816 52819 10.1074/jbc.C400445200 1:CAS:528:DC%2BD2cXhtVKqur3P (Pubitemid 40051780)
2. SC Aronoff 1988 Outer membrane permeability in Pseudomonas cepacia: diminished porin content in a beta-lactam-resistant mutant and in resistant cystic fibrosis isolates Antimicrob Agents Chemother 32 1636 1639 1:CAS:528:DyaL1MXkt1yh (Pubitemid 18267607)
3. S Asad SM Opal 2008 Bench to bedside review: quorum sensing and the role of cell to cell communication during invasive bacterial infection Crit Care 12 236 10.1186/cc7101
4. DF Aubert RS Flannagan MA Valvano 2008 A novel sensor-kinase response regulator hybrid controls biofilm formation and type VI secretion system activity in Burkholderia cenocepacia Infect Immun 76 1979 1991 10.1128/IAI.01338-07 1:CAS:528:DC%2BD1cXltlektbw%3D (Pubitemid 351656130)
5. S Bazzini C Udine A Sass MR Pasca F Longo G Emiliani M Fondi E Perrin F Decorosi C Viti L Giovannetti L Leoni R Fani G Riccardi E Mahenthiralingam S Buroni 2011 Deciphering the role of RND efflux transporters in Burkholderia cenocepacia PLoS One 6 e18902 10.1371/journal.pone.0018902 1:CAS:528: DC%2BC3MXlt1aisbg%3D
6. SP Bernier DT Nguyen PA Sokol 2008 A lysr-type transcriptional regulator in Burkholderia cenocepacia influences colony morphology and virulence Infect Immun 76 38 47 10.1128/IAI.00874-07 1:CAS:528:DC%2BD1cXisVKhsA%3D%3D
7. BR Bochner 2009 Global phenotypic characterization of bacteria FEMS Microbiol Rev 33 191 205 10.1111/j.1574-6976.2008.00149.x 1:CAS:528: DC%2BD1MXmtlKjsA%3D%3D
8. BR Bochner P Gadzinski E Panomitros 2001 Phenotype microarrays for high-throughput phenotypic testing and assay of gene function Genome Res 11 1246 1255 10.1101/gr.186501 1:CAS:528:DC%2BD3MXltFaitb0%3D (Pubitemid 32677299)
9. C Boon Y Deng LH Wang Y He JL Xu Y Fan SQ Pan LH Zhang 2008 A novel dsf-like signal from Burkholderia cenocepacia interferes with Candida albicans morphological transition ISME J 2 27 36 10.1038/ismej.2007.76 1:CAS:528:DC%2BD1cXitV2hsLw%3D (Pubitemid 351612352)
10. JL Burns DM Lien LA Hedin 1989 Isolation and characterization of dihydrofolate reductase from trimethoprim-susceptible and trimethoprim-resistant Pseudomonas cepacia Antimicrob Agents Chemother 33 1247 1251 1:CAS:528:DyaL1MXltFahsLo%3D (Pubitemid 19191966)
11. S Buroni MR Pasca RS Flannagan S Bazzini A Milano I Bertani V Venturi MA Valvano G Riccardi 2009 Assessment of three resistance-nodulation-cell division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance BMC Microbiol 9 200 10.1186/1471-2180-9-200
12. E Caraher G Reynolds P Murphy S McClean M Callaghan 2007 Comparison of antibiotic susceptibility of Burkholderia cepacia complex organisms when grown planktonically or as biofilm in vitro Eur J Clin Microbiol Infect Dis 26 213 216 10.1007/s10096-007-0256-x 1:CAS:528:DC%2BD2sXjsFygsLs%3D
13. YY Chan TM Tan YM Ong KL Chua 2004 BpeAB-OprB, a multidrug efflux pump in Burkholderia pseudomallei Antimicrob Agents Chemother 48 1128 1135 10.1128/AAC.48.4.1128-1135.2004 1:CAS:528:DC%2BD2cXjtVKrurc%3D (Pubitemid 38405465)
14. YY Chan HS Bian TM Tan ME Mattmann GD Geske J Igarashi T Hatano H Suga HE Blackwell KL Chua 2007 Control of quorum sensing by a Burkholderia pseudomallei multidrug efflux pump J Bacteriol 189 4320 4324 10.1128/JB.00003-07 1:CAS:528:DC%2BD2sXmt1Cjs7Y%3D (Pubitemid 46847382)
15. MV Cieri N Mayer-Hamblett A Griffith JL Burns 2002 Correlation between an in vitro invasion assay and a murine model of Burkholderia cepacia lung infection Infect Immun 70 1081 1086 10.1128/IAI.70.3.1081-1086.2002 1:CAS:528:DC%2BD38XhsFSmu7w%3D (Pubitemid 34163377)
16. T Coenye 2010 Response of sessile cells to stress: from changes in gene expression to phenotypic adaptation FEMS Immunol Med Microbiol 59 239 252 1:CAS:528:DC%2BC3cXhtVeju77N
17. T Coenye H Van Acker E Peeters A Sass S Buroni G Riccardi E Mahenthiralingam 2011 Molecular mechanisms of chlorhexidine tolerance in Burkholderia cenocepacia biofilms Antimicrob Agents Chemother 55 1912 1919 10.1128/AAC.01571-10
18. BA Conway V Venu DP Speert 2002 Biofilm formation and acyl homoserine lactone production in the Burkholderia cepacia complex J Bacteriol 184 5678 5685 10.1128/JB.184.20.5678-5685.2002 1:CAS:528:DC%2BD38Xns1Citrk%3D
19. MV Cunha SA Sousa JH Leitão LM Moreira PA Videira I Sá-Correia 2004 Studies on the involvement of the exopolysaccharide produced by cystic fibrosis-associated isolates of the Burkholderia cepacia complex in biofilm formation and in persistence of respiratory infections J Clin Microbiol 42 3052 3058 10.1128/JCM.42.7.3052-3058.2004 1:CAS:528: DC%2BD2cXntFGktrs%3D (Pubitemid 38938057)
20. MC da Silva JM Zahm D Gras O Bajolet M Abely J Hinnrasky M Milliot MC de Assis C Hologne N Bonnet M Merten MC Plotkowski E Puchelle 2004 Dynamic interaction between airway epithelial cells and Staphylococcus aureus Am J Physiol Lung Cell Mol Physiol 287 L543 L551 10.1152/ajplung.00256.2003 (Pubitemid 39095910)
21. Y Deng C Boon L Eberl LH Zhang 2009 Differential modulation of Burkholderia cenocepacia virulence and energy metabolism by the quorum-sensing signal BDSF and its synthase J Bacteriol 191 7270 7278 10.1128/JB.00681-09 1:CAS:528:DC%2BD1MXhsVyrtrnK
22. P Drevinek E Mahenthiralingam 2010 Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence Clin Microbiol Infect 16 821 830 10.1111/j.1469-0691.2010.03237.x 1:CAS:528: DC%2BC3cXpslylu74%3D
23. P Drevinek MT Holden Z Ge AM Jones I Ketchell RT Gill E Mahenthiralingam 2008 Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum BMC Infect Dis 8 121 10.1186/1471-2334-8-121
24. C Duff PG Murphy M Callaghan S McClean 2006 Differences in invasion and translocation of Burkholderia cepacia complex species in polarized lung epithelial cells in vitro Microb Pathog 41 183 192 10.1016/j.micpath.2006.07.005 1:CAS:528:DC%2BD28Xps1Cjur4%3D (Pubitemid 44374301)
25. AB Estrela MG Heck WR Abraham 2009 Novel approaches to control biofilm infections Curr Med Chem 16 1512 1530 10.2174/092986709787909640 1:CAS:528:DC%2BD1MXltVeqt74%3D
26. RS Flannagan T Linn MA Valvano 2008 A system for the construction of targeted unmarked gene deletions in the genus Burkholderia Environ Microbiol 10 1652 1660 10.1111/j.1462-2920.2008.01576.x 1:CAS:528:DC%2BD1cXnvVWku78%3D (Pubitemid 351670258)
27. S Fraud AJ Campigotto Z Chen K Poole 2008 MexCD-OprJ multidrug efflux system of Pseudomonas aeruginosa: involvement in chlorhexidine resistance and induction by membrane-damaging agents dependent upon the AlgU stress response sigma factor Antimicrob Agents Chemother 52 4478 4482 10.1128/AAC.01072-08 1:CAS:528:DC%2BD1cXhsV2mu7%2FK
28. P Guglierame MR Pasca E De Rossi S Buroni P Arrigo G Manina G Riccardi 2006 Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome BMC Microbiol 6 66 10.1186/1471-2180-6-66 (Pubitemid 44252725)
29. MA Hamad AM Skeldon MA Valvano 2010 Construction of aminoglycoside- sensitive Burkholderia cenocepacia strains for use in studies of intracellular bacteria with the gentamicin protection assay Appl Environ Microbiol 76 3170 3176 10.1128/AEM.03024-09 1:CAS:528:DC%2BC3cXmsF2ltb8%3D
30. MK Higgins E Bokma E Koronakis C Hughes V Koronakis 2004 Structure of the periplasmic component of a bacterial drug efflux pump Proc Natl Acad Sci USA 101 9994 9999 10.1073/pnas.0400375101 1:CAS:528:DC%2BD2cXlvFOiu7s%3D (Pubitemid 38891184)
31. MT Holden HM Seth-Smith LC Crossman M Sebaihia SD Bentley AM Cerdeño-Tárraga NR Thomson N Bason MA Quail S Sharp I Cherevach C Churcher I Goodhead H Hauser N Holroyd K Mungall P Scott D Walker B White H Rose P Iversen D Mil-Homens EP Rocha AM Fialho A Baldwin C Dowson BG Barrell JR Govan P Vandamme CA Hart E Mahenthiralingam J Parkhill 2009 The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients J Bacteriol 191 261 277 10.1128/JB.01230-08 1:CAS:528:DC%2BD1MXoslChs78%3D
32. B Huber K Riedel M Köthe M Givskov S Molin L Eberl 2002 Genetics analysis of functions involved in the late stages of biofilm development in Burkholderia cepacia H111 Mol Microbiol 46 411 426 10.1046/j.1365-2958.2002. 03182.x 1:CAS:528:DC%2BD38XosVarsbc%3D (Pubitemid 35340953)
33. KK Huynh JD Plumb GP Downey MA Valvano S Grinstein 2010 Inactivation of macrophage Rab7 by Burkholderia cenocepacia J Innate Immun 2 522 533 10.1159/000319864 1:CAS:528:DC%2BC3cXht12lurzK
34. AM Jones ME Dodd AK Webb 2001 Burkholderia cepacia: current clinical issues, environmental controversies and ethical dilemmas Eur Respir J 17 295 301 10.1183/09031936.01.17202950 1:STN:280:DC%2BD3M3jvVCmtw%3D%3D (Pubitemid 32600590)
35. A Lee W Mao MS Warren A Mistry K Hoshino R Okumura H Ishida O Lomovskaya 2000 Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance J Bacteriol 182 3142 3150 10.1128/JB.182.11.3142-3150.2000 1:CAS:528:DC%2BD3cXjsVyltLs%3D (Pubitemid 30326929)
36. S Lewenza MB Visser PA Sokol 2002 Interspecies communication between Burkholderia cepacia and Pseudomonas aeruginosa Can J Microbiol 48 707 716 10.1139/w02-068 1:CAS:528:DC%2BD38Xnsl2mu7Y%3D (Pubitemid 35370786)
37. XZ Li H Nikaido 2009 Efflux-mediated drug resistance in bacteria: an update Drugs 69 1555 1623 10.2165/11317030-000000000-00000 1:CAS:528: DC%2BD1MXht1ehtLfI
38. JJ LiPuma 2010 The changing microbial epidemiology in cystic fibrosis Clin Microbiol Rev 23 299 323 10.1128/CMR.00068-09
39. SA Loutet MA Valvano 2010 A decade of Burkholderia cenocepacia virulence determinant research Infect Immun 78 4088 4100 10.1128/IAI.00212-10 1:CAS:528:DC%2BC3cXht12js7%2FP
40. JB Lyczak CL Cannon GB Pier 2002 Lung infections associated with cystic fibrosis Clin Microbiol Rev 15 194 222 10.1128/CMR.15.2.194-222.2002 1:CAS:528:DC%2BD38XjslGrurk%3D (Pubitemid 34303763)
41. A Madeira PM Santos CP Coutinho A Pinto-de-Oliveira I Sá-Correia 2011 Quantitative proteomics (2-D DIGE) reveals molecular strategies employed by Burkholderia cenocepacia to adapt to the airways of cystic fibrosis patients under antimicrobial therapy Proteomics 11 1313 1328 10.1002/pmic.201000457 1:CAS:528:DC%2BC3MXjslCgurc%3D
42. E Mahenthiralingam A Baldwin CG Dowson 2008 Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology J Appl Microbiol 104 1539 1551 10.1111/j.1365-2672.2007.03706.x 1:STN:280: DC%2BD1czjtVOitw%3D%3D (Pubitemid 351724983)
43. S McClean M Callaghan 2009 Burkholderia cepacia complex: epithelial cell-pathogen confrontations and potential for therapeutic intervention J Med Microbiol 58 1 12 10.1099/jmm.0.47788-0 1:CAS:528:DC%2BD1MXhslWjsrc%3D
44. S McKeon S McClean M Callaghan 2010 Macrophage responses to CF pathogens: JNK MAP kinase signaling by Burkholderia cepacia complex lipopolysaccharide FEMS Immunol Med Microbiol 60 36 43 10.1111/j.1574-695X.2010.00712.x 1:CAS:528:DC%2BC3cXht1Cmtr3F
45. SA McKeon DT Nguyen DF Viteri JE Zlosnik PA Sokol 2011 Functional quorum sensing systems are maintained during chronic Burkholderia cepacia complex infections in patients with cystic fibrosis J Infect Dis 203 383 392 10.1093/infdis/jiq054 1:CAS:528:DC%2BC3MXnsVWnsA%3D%3D
46. D Mil-Homens EP Rocha AM Fialho 2010 Genome-wide analysis of DNA repeats in Burkholderia cenocepacia J2315 identifies a novel adhesin-like gene unique to epidemic-associated strains of the ET-12 lineage Microbiology 156 1084 1096 10.1099/mic.0.032623-0 1:CAS:528:DC%2BC3cXmtFemsbw%3D
47. R Misra VN Bavro 2009 Assembly and transport mechanism of tripartite drug efflux systems Biochim Biophys Acta 1794 817 825 1:CAS:528:DC%2BD1MXkvVSrtr8%3D
48. RA Moore RE Hancock 1986 Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance Antimicrob Agents Chemother 30 923 926 1:CAS:528:DyaL2sXkslWhsw%3D%3D (Pubitemid 17209150)
49. RA Moore D DeShazer S Reckseidler A Weissman DE Woods 1999 Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei Antimicrob Agents Chemother 43 465 470 1:CAS:528:DyaK1MXhsF2ht7Y%3D (Pubitemid 29109504)
50. JA Moura M Cristina de Assis GC Ventura AM Saliba L Gonzaga Jr M Si-Tahar A Marques Ede MC Plotkowski 2008 Differential interaction of bacterial species from the Burkholderia cepacia complex with human airway epithelial cells Microbes Infect 10 52 59 10.1016/j.micinf.2007.10.002 1:CAS:528: DC%2BD1cXhslehu70%3D
51. T Mullen K Markey P Murphy S McClean M Callaghan 2007 Role of lipase in Burkholderia cepacia complex (Bcc) invasion of lung epithelial cells Eur J Clin Microbiol Infect Dis 26 869 877 10.1007/s10096-007-0385-2 1:CAS:528: DC%2BD2sXht1OksrzO (Pubitemid 350077211)
52. T Mullen M Callaghan S McClean 2010 Invasion of Burkholderia cepacia complex isolates into lung epithelial cells involves glycolipid receptors Microb Pathog 49 381 387 10.1016/j.micpath.2010.08.003 1:CAS:528:DC%2BC3cXhtlWjsrfK
53. S Murakami R Nakashima E Yamashita A Yamaguchi 2002 Crystal structure of bacterial multidrug efflux transporter AcrB Nature 419 587 593 10.1038/nature01050 1:CAS:528:DC%2BD38Xns1Ontr0%3D
54. BM Nair KJ Cheung Jr A Griffith JL Burns 2004 Salicylate induces an antibiotic efflux pump in Burkholderia cepacia complex genomovar III (B. cenocepacia) J Clin Investig 113 464 473 1:CAS:528:DC%2BD2cXhtFSlsL4%3D (Pubitemid 38544190)
55. H Nikaido Y Takatsuka 2009 Mechanisms of RND multidrug efflux pumps Biochim Biophys Acta 1794 769 781 1:CAS:528:DC%2BD1MXkvVSrsbk%3D
56. EP O'Grady DF Viteri RJ Malott PA Sokol 2009 Reciprocal regulation by the CepIR and CciIR quorum sensing systems in Burkholderia cenocepacia BMC Genomics 10 441 10.1186/1471-2164-10-441
57. MG Page J Heim 2009 Prospects for the next anti-Pseudomonas drug Curr Opin Pharmacol 9 558 565 10.1016/j.coph.2009.08.006 1:CAS:528:DC%2BD1MXht1WntLnP
58. JM Pagès M Masi J Barbe 2005 Inhibitors of efflux pumps in Gram-negative bacteria Trends Mol Med 11 382 389 10.1016/j.molmed.2005.06.006 (Pubitemid 41080580)
59. TR Parr Jr RA Moore LV Moore RE Hancock 1987 Role of porins in intrinsic antibiotic resistance of Pseudomonas cepacia Antimicrob Agents Chemother 31 121 123 1:CAS:528:DyaL2sXpvFSmsA%3D%3D (Pubitemid 17212673)
60. E Peeters HJ Nelis T Coenye 2009 In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/ sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria J Antimicrob Chemother 64 801 809 10.1093/jac/dkp253 1:CAS:528:DC%2BD1MXhtFarsr3O
61. E Perrin M Fondi MC Papaleo I Maida S Buroni MR Pasca G Riccardi R Fani 2010 Exploring the HME and HAE1 efflux systems in the genus Burkholderia BMC Evol Biol 10 164 10.1186/1471-2148-10-164
62. K Riedel P Carranza P Gehrig F Potthast L Eberl 2006 Towards the proteome of Burkholderia cenocepacia H111: setting up a 2-DE reference map Proteomics 6 207 216 10.1002/pmic.200500097 1:CAS:528:DC%2BD28XpsVSitg%3D%3D (Pubitemid 43142946)
63. J Riethmüller A Riehle H Grassmé E Gulbins 2006 Membrane rafts in host-pathogen interactions Biochim Biophys Acta 1758 2139 2147 10.1016/j.bbamem.2006.07.017 (Pubitemid 44879365)
64. JR Riordan 2008 CFTR function and prospects for therapy Annu Rev Biochem 77 701 726 10.1146/annurev.biochem.75.103004.142532 1:CAS:528: DC%2BD1cXos1eku7o%3D
65. RP Ryan Y McCarthy SA Watt K Niehaus JM Dow 2009 Intraspecies signaling involving the diffusible signal factor BDSF (cis-2-dodecenoic acid) influences virulence in Burkholderia cenocepacia J Bacteriol 191 5013 5019 10.1128/JB.00473-09 1:CAS:528:DC%2BD1MXptlehsLs%3D
66. L Saiman J Siegel 2003 Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission J Infect Control Hosp Epidemiol 24 S6 S52 10.1086/503485
67. MS Saldías MA Valvano 2009 Interactions of Burkholderia cenocepacia and other Burkholderia cepacia complex bacteria with epithelial and phagocytic cells Microbiology 155 2809 2817 10.1099/mic.0.031344-0
68. MS Saldías J Lamothe R Wu MA Valvano 2008 Burkholderia cenocepacia requires the RpoN sigma factor for biofilm formation and intracellular trafficking within macrophages Infect Immun 76 1059 1067 10.1128/IAI.01167-07 (Pubitemid 351428065)
69. MS Saldías X Ortega MA Valvano 2009 Burkholderia cenocepacia O antigen lipopolysaccharide prevents phagocytosis by macrophages and adhesion to epithelial cells J Med Microbiol 58 1542 1548 10.1099/jmm.0.013235-0
70. A Sass A Marchbank E Tullis JJ LiPuma E Mahenthiralingam 2011 Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis BMC Genomics 12 373 10.1186/1471-2164-12-373 1:CAS:528:DC%2BC3MXhtVKgtL%2FI
71. I Simonovic M Arpin A Koutsouris HJ Falk-Krzesinski G Hecht 2001 Enteropathogenic Escherichia coli activates ezrin, which participates in disruption of tight junction barrier function Infect Immun 69 5679 5688 10.1128/IAI.69.9.5679-5688.2001 1:CAS:528:DC%2BD3MXmsVarsLg%3D (Pubitemid 32786506)
72. PA Sokol U Sajjan MB Visser S Gingues J Forstner C Kooi 2003 The CepIR quorum-sensing system contributes to the virulence of Burkholderia cenocepacia respiratory infections Microbiology 149 3649 3658 10.1099/mic.0.26540-0 1:CAS:528:DC%2BD3sXhtVWnsL3I (Pubitemid 38016691)
73. M Tomich CA Herfst JW Golden CD Mohr 2002 Role of flagella in host cell invasion by Burkholderia cepacia Infect Immun 70 1799 1806 10.1128/IAI.70.4. 1799-1806.2002 1:CAS:528:DC%2BD38Xitl2murw%3D (Pubitemid 34242179)
74. S Trépanier A Prince A Huletsky 1997 Characterization of the penA and penR genes of Burkholderia cepacia 249 which encode the chromosomal class A penicillinase and its LysR-type transcriptional regulator Antimicrob Agents Chemother 41 2399 2405 (Pubitemid 27467547)
75. TA Urban JB Goldberg JF Forstner US Sajjan 2005 Cable pili and the 22-kilodalton adhesin are required for Burkholderia cenocepacia binding to and transmigration across the squamous epithelium Infect Immun 73 5426 5437 10.1128/IAI.73.9.5426-5437.2005 1:CAS:528:DC%2BD2MXps1GksLk%3D (Pubitemid 41192977)
76. L Vial A Chapalain MC Groleau E Déziel 2011 The various lifestyles of the Burkholderia cepacia complex species: a tribute to adaptation Environ Microbiol 13 1 12 10.1111/j.1462-2920.2010.02343.x 1:CAS:528: DC%2BC3MXhsl2nurs%3D
77. Y Wei GT Ryan AL Flores-Mireles ED Costa DJ Schneider SC Winans 2011 Saturation mutagenesis of a CepR binding site as a means to identify new quorum-regulated promoters in Burkholderia cenocepacia Mol Microbiol 79 616 632 10.1111/j.1365-2958.2010.07469.x 1:CAS:528:DC%2BC3MXisFKltL4%3D
78. DR Yoder-Himes PSG Chain Y Zhu O Wurtzel EM Rubin JM Tiedje R Sorek 2009 Mapping the Burkholderia cenocepacia niche response via high-throughput sequencing Proc Natl Acad Sci USA 106 3976 3981 10.1073/pnas.0813403106 1:CAS:528:DC%2BD1MXjt1Gkt7w%3D
79. DR Yoder-Himes KT Konstantinidis JM Tiedje 2010 Identification of potential therapeutic targets for Burkholderia cenocepacia by comparative transcriptomics PLoS One 5 e8724 10.1371/journal.pone.0008724
80. L Zulianello C Canard T Köhler D Caille JS Lacroix P Meda 2006 Rhamnolipids are virulence factors that promote early infiltration of primary human airway epithelia by Pseudomonas aeruginosa Infect Immun 74 3134 3147 10.1128/IAI.01772-05 1:CAS:528:DC%2BD28Xlt1CgtLo%3D (Pubitemid 43794502)